Skip to main content

Table 1 Potential biomarkers of diabetic cardiomyopathy in rats

From: Changes of myocardial lipidomics profiling in a rat model of diabetic cardiomyopathy using UPLC/Q-TOF/MS analysis

No.

tR (min)

Mass-to-charge (m/z) ratios

VIP values

P value

DCM model versus control

Chemical names

Structure

Fold values

Positive mode

 1

5.7270

830.5688

4.75926

0.000298

↓

PC (22:6/18:2)

C48H80NO8P

2.3550

 2

6.2368

832.5842

1.82151

0.000235

↓

PC (22:6/18:1)

C48H82NO8P

2.0013

 3

6.6324

764.5216

1.83260

8.78E−05

↓

PE (20:4/18:2)

C43H74NO8P

2.1611

 4

8.2759

810.5986

1.21197

0.041959

↑

PC (20:2/18:2)

C46H84NO8P

2.3574

 5

8.3776

784.5834

2.92017

0.000513

↑

PC (18:0/16:0)

C42H84NO8P

4.3254

 6

8.6115

810.5998

1.89759

1.46E−05

↑

PC (20:4/18:0) or PC (20:3/18:1)

C46H84NO8P

6.7733

 7

5.8249

780.5525

1.86694

0.001519

↓

PC (20:4/16:1)

C44H78NO8P

3.3939

 8

5.6524

754.5370

1.27221

0.000592

↓

PC (16:1/18:3)

C42H76NO8P

4.4684

 9

9.2400

780.5890

1.23109

0.001364

↓

PE (20:4/16:0)

C41H74NO8P

3.3926

  1. PC, phosphatidylcholine; PE, phosphatidylethanolamine; tR, retention time; VIP, variable importance in projection; DCM, diabetic cardiomyopathy